96
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Visual evoked potentials after panretinal photocoagulation in patients with proliferative diabetic retinopathy

, &
Pages 1635-1640 | Published online: 28 Aug 2019

References

  • Sarwar N, Gao P, Seshasai SRK, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (London, England). 2010;375(9733):2215–2222. doi:10.1016/S0140-6736(10)60484-9
  • Lieth E, Gardner TW, Barber AJ, Antonetti DA. Retinal neurodegeneration: early pathology in diabetes. Clin Exp Ophthalmol. 2000;28(1):3–8.
  • Heravian J, Ehyaei A, Shoeibi N, et al. Pattern visual evoked potentials in patients with type II diabetes mellitus. J Ophthalmic Vis Res. 2012;7(3):225–230.
  • Cohen SR, Gardner TW. Diabetic retinopathy and diabetic macular edema. Dev Ophthalmol. 2015;55:137–146.
  • Wu G. Diabetic Retinopathy-The Essentials. 1st ed. Philadelphia: Lippincott Williams & Wilkins; 2010.
  • Celesia GG, Polcyn RD, Holden JE, Nickles RJ, Gatley JS, Koeppe RA. Visual evoked potentials and positron emission tomographic mapping of regional cerebral blood flow and cerebral metabolism: can the neuronal potential generators be visualized? Electroencephalogr Clin Neurophysiol. 1982;54(3):243–256. doi:10.1016/0013-4694(82)90174-2
  • American Society of Retina Specialists (ASRS) global trends in retina survey results; 2015. Available from: https://www.asrs.org/content/documents/2014_global_trends_comprehensivepostmtg.pdf. Accessed February 18, 2015.
  • Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064–1077. doi:10.1016/j.ophtha.2010.02.031
  • Stewart MW. Treatment of diabetic retinopathy: recent advances and unresolved challenges. World J Diabetes. 2016;7(16):333–341. doi:10.4239/wjd.v7.i16.333
  • Parisi V, Uccioli L. Visual electrophysiological responses in persons with type 1 diabetes. Diabetes Metab Res Rev. 2001;17(1):12–18. doi:10.1002/(ISSN)1520-7560
  • Horton JC, Hoyt WF. The representation of the visual field in the human striate cortex. Arch Ophthalmol. 1991;109:816–824. doi:10.1001/archopht.1991.01080060080030
  • American Academy of Ophthalmology Retina/Vitreous Panel Preferred Practice Pattern Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; November 2016. Available from: http://www.aao.org/ppp.
  • Kolappan M, Henderson APD, Jenkins TM, et al. Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. J Neurol. 2009;256(3):305–319. doi:10.1007/s00415-009-5123-5
  • Mooradian AD. Pathophysiology of central nervous system complications in diabetes mellitus. Clin Neurosci. 1997;4(6):322–326.
  • Matsubara JA, Lam DY, Kalil RE, et al. The effects of panretinal photocoagulation on the primary visual cortex of the adult monkey. Trans Am Ophthalmol Soc. 2001;99:33.
  • Little HL, Zweng HC, Peabody RR. Argon laser slit-lamp retinal photocoagulation. Trans Am Acad Ophthalmol Otolaryngol. 1970;74(1):85–97.
  • Fong DS, Girach A, Boney A. Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review. Retina. 2007;27(7):816–824.
  • Horton JC, Hocking DR. Monocular core zones and binocular border strips in primate striate cortex revealed by the contrasting effects of enucleation, eyelid suture, and retinal laser lesions on cytochrome oxidase activity. J Neurosci. 1998;18(14):5433–5455. doi:10.1523/JNEUROSCI.18-14-05433.1998
  • Shenoy R, Al-Belushi H, Al-Ajmi S, Al-Nabhani SM, Ganguly SS, Bialasiewicz AA. Visually evoked potentials after panretinal photocoagulation in omani patients with uncontrolled diabetes mellitus. Middle East Afr J Ophthalmol. 2008;15(2):51–56. doi:10.4103/0974-9233.51992
  • Gregori B, Galié E, Pro S, Clementi A, Accornero N. Luminance and chromatic visual evoked potentials in type I and type II diabetes: relationships with peripheral neuropathy. Neurol Sci. 2006;27(5):323–327. doi:10.1007/s10072-006-0704-x
  • Cirillo D, Gonfiantini E, De Grandis D, Bongiovanni L, Robert JJ, Pinelli L. Visual evoked potentials in diabetic children and adolescents. Diabetes Care. 1984;7(3):273–275.
  • Mariani E, Moreo G, Colucci GB. Study of visual evoked potentials in diabetics without retinopathy: correlations with clinical findings and polyneuropathy. Acta Neurol Scand. 1990;81(4):337–340. doi:10.1111/j.1600-0404.1990.tb01566.x
  • Puvanendran K, Devathasan G, Wong PK. Visual evoked responses in diabetes. J Neurol Neurosurg Psychiatry. 1983;46(7):643–647. doi:10.1136/jnnp.46.7.643
  • Gupta S, Gupta G, Deshpande VK. Visual evoked potential changes in patients with diabetes mellitus without retinopathy. Int J Res Med Sci. 2017;3(12):3591–3598.
  • Lopes de Faria JM, Katsumi O, Cagliero E, Nathan D, Hirose T. Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus. Graefe’s Arch Clin Exp Ophthalmol. 2001;239(9):643–648. doi:10.1007/s004170100268
  • Gottlob I, Prskavec FH, Stelzer N, Hienert I, Weghaupt H, Radda TM. Reversible changes of visual acuity and pattern-electroretinograms after blue-green argon laser photocoagulation of diabetic patients. Doc Ophthalmol. 1989;72(2):105–113. doi:10.1007/BF00156700
  • ÖNER A, AKARSU C, ARDA H, GÜMÜŞ K, KARAKÜÇÜK S, MİRZA E. Electrophysiologic changes after panretinal argon laser photocoagulation in patients with diabetic retinopathy. J Retin. 2015;23:1.
  • Kaufman SC, Ferris FL, Seigel DG, Davis MD, DeMets DL. Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Diabetic retinopathy study report #13. Invest Ophthalmol Vis Sci. 1989;30(1):23–28.